A Study of SGN-ALPV in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Suzanne McGoldrick, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
- University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada
- Start Madrid-Ciocc_hospital Hm Sanchinarro
Madrid, Other, Spain
- Karolinska University Hospital
Stockholm, Other, Sweden
- Sarah Cannon Research Institute Uk
London, Other, United Kingdom
- the Royal Marsden Nhs Foundation Trust (rm)
London, Other, United Kingdom
- Women'S Cancer Care
Fresno, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Florida Cancer Specialists - Lake Nona
Wellington, Florida, United States
- Start Midwest
Grand Rapids, Michigan, United States
- Oklahoma University at Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
- Start Mountain Region
West Valley City, Utah, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Apr 2022
- Primary completion
- 13 Dec 2023
- Completion
- 13 Dec 2023
- Last update posted
- 10 Feb 2025
- Registered enrollment
- 43
- Registry id
- NCT05229900
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.